Northern Trust Portfolio holdings
Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$534M |
| 2 |
FlexShares iBoxx 3-Year Target Duration TIPS Index Fund
TDTT
|
+$477M |
| 3 |
S&P Global
SPGI
|
+$430M |
| 4 |
FlexShares Global Upstream Natural Resources Index Fund
GUNR
|
+$303M |
| 5 |
FlexShares High Yield Value-Scored Bond Index Fund
HYGV
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$815M |
| 2 |
XLNX
Xilinx Inc
XLNX
|
+$629M |
| 3 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$520M |
| 4 |
Microsoft
MSFT
|
+$511M |
| 5 |
Amazon
AMZN
|
+$298M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.63% |
| 2 | Healthcare | 12.57% |
| 3 | Financials | 12.04% |
| 4 | Consumer Discretionary | 10.68% |
| 5 | Industrials | 7.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3376
Verrica Pharmaceuticals
VRCA
$90.2M
| $1.1M | ﹤0.01% |
13,596
-388
| -3% | -$32K |
|
|
ATHX
3377
DELISTED
Athersys, Inc. Common Stock
ATHX
| $1.1M | ﹤0.01% |
72,656
-2,197
| -3% | -$46K |
|
3378
Quantum Corp
QMCO
$416M
| $1.1M | ﹤0.01% |
24,179
-544
| -2% | -$39.9K |
|
|
PNT
3379
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $1.09M | ﹤0.01% |
136,882
-2,436
| -2% | -$15.5K |
|
|
APEN
3380
DELISTED
Apollo Endosurgery, Inc.
APEN
| $1.08M | ﹤0.01% |
179,377
-3,246
| -2% | -$19.8K |
|
3381
Samsara
IOT
$21.6B
| $1.08M | ﹤0.01% |
+67,608
| New | +$1.29M |
|
3382
Vanguard S&P 500 Growth ETF
VOOG
$26.4B
| $1.08M | ﹤0.01% |
23,544
| – | – |
|
3383
Vertex
VERX
$2.17B
| $1.08M | ﹤0.01% |
70,513
+2,071
| +3% | +$29K |
|
|
SBDS
3384
DELISTED
Solo Brands Inc
SBDS
| $1.08M | ﹤0.01% |
3,164
+315
| +11% | +$139K |
|
|
MPX
3385
DELISTED
Marine Products Corp
MPX
| $1.08M | ﹤0.01% |
93,455
-3,375
| -3% | -$40.8K |
|
3386
GitLab
GTLB
$6.01B
| $1.08M | ﹤0.01% |
19,778
+1,325
| +7% | +$79.1K |
|
|
PSTX
3387
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $1.07M | ﹤0.01% |
239,289
-12,504
| -5% | -$56.4K |
|
3388
Angi Inc
ANGI
$240M
| $1.07M | ﹤0.01% |
18,888
-124
| -0.7% | -$9.04K |
|
3389
Tyra Biosciences
TYRA
$1.91B
| $1.07M | ﹤0.01% |
100,104
-3,389
| -3% | -$40.2K |
|
3390
Shattuck Labs
STTK
$696M
| $1.07M | ﹤0.01% |
250,869
-19,503
| -7% | -$111K |
|
3391
Janus International
JBI
$739M
| $1.07M | ﹤0.01% |
118,635
+2,849
| +2% | +$28.9K |
|
3392
Ternium
TX
$9.76B
| $1.07M | ﹤0.01% |
23,356
+17,032
| +269% | +$725K |
|
3393
Clear Secure
YOU
$5.56B
| $1.07M | ﹤0.01% |
39,672
+6,730
| +20% | +$167K |
|
3394
Holley
HLLY
$332M
| $1.06M | ﹤0.01% |
76,036
-1,513
| -2% | -$19.4K |
|
3395
Amylyx Pharmaceuticals
AMLX
$2.24B
| $1.06M | ﹤0.01% |
+82,170
| New | +$1.86M |
|
|
OMGA
3396
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $1.05M | ﹤0.01% |
168,990
+96,196
| +132% | +$982K |
|
|
NAGE
3397
Niagen Bioscience
NAGE
$281M
| $1.05M | ﹤0.01% |
428,817
-20,645
| -5% | -$56.4K |
|
|
CARM
3398
DELISTED
Carisma Therapeutics
CARM
| $1.05M | ﹤0.01% |
86,840
-3,023
| -3% | -$42.2K |
|
|
TBHC
3399
DELISTED
The Brand House Collective
TBHC
| $1.05M | ﹤0.01% |
112,794
-8,116
| -7% | -$116K |
|
3400
Crawford & Co Class A
CRD.A
$552M
| $1.05M | ﹤0.01% |
138,500
-6,496
| -4% | -$49.3K |
|
Similar funds
Northern Trust's Q1 2022 Portfolio in Review
As of Q1 2022, Northern Trust held 4,890 positions worth $568B, down 6.9% from $610B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Northern Trust's Q1 2022 filing shows 117 new, 934 increased, 3,288 reduced and 148 closed positions. Its largest new stake was Constellation Energy: 3,275,992 shares worth $184M. The largest sale was Apple, an estimated $815M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.
- Northern Trust's largest Q1 2022 buy was Constellation Energy: 3,275,992 shares worth $184M.
- Northern Trust added most to Advanced Micro Devices in Q1 2022, an estimated $534M increase.
- Northern Trust's biggest Q1 2022 reduction was Apple, cutting an estimated $815M.
- Northern Trust fully exited Xilinx Inc in Q1 2022, selling an estimated $629M.
- Northern Trust's ten largest holdings make up 23% of its $568B portfolio in Q1 2022.
- Northern Trust opened 117 new positions and closed 148 in Q1 2022.
- Northern Trust's portfolio value fell 6.9% quarter-over-quarter to $568B.
Based on Northern Trust's 13F filing for Q1 2022, filed 13 May 2022.